Literature DB >> 26885269

Overexpression of miR-506 inhibits growth of osteosarcoma through Snail2.

Zhongxiang Yu1, Yuting Zhang2, Ningyang Gao1, Xiang Wang1.   

Abstract

Osteosarcoma (OS) is a prevalent primary bone malignancy and its distal metastasis accounts for the majority of OS-related death. MicroRNAs (miRNAs) play critical roles during cancer metastasis. Thus, elucidation of the involvement of specific miRNAs in the metastasis of OS may provide novel therapeutic targets for OS treatment. Here, we showed that in the OS specimens from patients, the levels of miR-506 were significantly decreased and the levels of Snail2 were significantly increased, compared to the paired normal bone tissue. MiR-506 and Snail2 inversely correlated in patients' specimen. Bioinformatics analyses predicted that miR-506 may target the 3'-UTR of Snail2 mRNA to inhibit its translation, which was confirmed by luciferase-reporter assay. Moreover, miR-506 overexpression inhibited Snail2-mediated cell invasiveness, while miR-506 depletion increased Snail2-mediated cell invasiveness in OS cells. Together, our data suggest that miR-506 suppression in OS cells may promote Snail2-mediated cancer metastasis.

Entities:  

Keywords:  Osteosarcoma (OS); Snail2; miR-506

Year:  2015        PMID: 26885269      PMCID: PMC4731669     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  28 in total

1.  Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma.

Authors:  H Tsuchiya; K Tomita; Y Mori; N Asada; T Morinaga; S Kitano; N Yamamoto
Journal:  Anticancer Res       Date:  1998 Jan-Feb       Impact factor: 2.480

2.  Two established in vitro cell lines from human mesenchymal tumours.

Authors:  J Pontén; E Saksela
Journal:  Int J Cancer       Date:  1967-09-15       Impact factor: 7.396

3.  MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma.

Authors:  Fei Wang; Weizhong Xiao; Jiyong Sun; Donghua Han; Youhou Zhu
Journal:  Tumour Biol       Date:  2014-05-28

4.  MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer.

Authors:  Gang Liu; Chuanshen Jiang; Dazhou Li; Rong Wang; Wen Wang
Journal:  Tumour Biol       Date:  2014-07-01

5.  MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3.

Authors:  Xianzhao Deng; Bo Wu; Ke Xiao; Jie Kang; Jing Xie; Xiaoping Zhang; Youben Fan
Journal:  Cell Physiol Biochem       Date:  2015-01-02

6.  The proapoptotic effect of formononetin in human osteosarcoma cells: involvement of inactivation of ERK and Akt pathways.

Authors:  Yun Liu; JinJie He; XiaoMing Chen; Jian Li; MaoRong Shen; WenJun Yu; Yuan Yang; ZengMing Xiao
Journal:  Cell Physiol Biochem       Date:  2014-08-12

7.  Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells.

Authors:  Tuo Yang; Miaomiao Chen; Tieying Sun
Journal:  Cell Physiol Biochem       Date:  2013-06-11

Review 8.  New molecular insights into osteosarcoma targeted therapy.

Authors:  Jilong Yang; Wei Zhang
Journal:  Curr Opin Oncol       Date:  2013-07       Impact factor: 3.645

9.  MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion.

Authors:  Qiang Wang; Jun Cai; Jingcheng Wang; Chuanzhi Xiong; Jianning Zhao
Journal:  Tumour Biol       Date:  2014-09-17

10.  Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo.

Authors:  Qiang Mei; Fang Li; Hongyu Quan; Yunlai Liu; Haidong Xu
Journal:  Cancer Sci       Date:  2014-07-03       Impact factor: 6.716

View more
  14 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  miR-1297 regulates neural stem cell differentiation and viability through controlling Hes1 expression.

Authors:  Jiaolin Zheng; Dan Yi; Xiaodong Shi; Huaizhang Shi
Journal:  Cell Prolif       Date:  2017-05-02       Impact factor: 6.831

3.  Long noncoding RNA RHPN1-AS1 exerts pro-oncogenic actions in osteosarcoma by functioning as a molecular sponge of miR-506 to positively regulate SNAI2 expression.

Authors:  Limin Wang; Yanbing Liu
Journal:  Cell Cycle       Date:  2020-05-13       Impact factor: 4.534

Review 4.  Regulatory effects of lncRNAs and miRNAs on the crosstalk between autophagy and EMT in cancer: a new era for cancer treatment.

Authors:  Lihui Si; Zecheng Yang; Lu Ding; Duoduo Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-27       Impact factor: 4.553

5.  MicroRNA-411 promoted the osteosarcoma progression by suppressing MTSS1 expression.

Authors:  Ning Xu; Weiliang Yang; Yang Liu; Feng Yan; Zhange Yu
Journal:  Environ Sci Pollut Res Int       Date:  2018-02-16       Impact factor: 4.223

6.  MiR-506 exerts antineoplastic effects on osteosarcoma cells via inhibition of the Skp2 oncoprotein.

Authors:  Lu Ding; Rongxin Sun; Qi Yan; Chengwei Wang; Xiaoping Han; Yong Cui; Rong Li; Jiwen Liu
Journal:  Aging (Albany NY)       Date:  2021-02-17       Impact factor: 5.682

7.  MicroRNA-124 acts as a tumor-suppressive miRNA by inhibiting the expression of Snail2 in osteosarcoma.

Authors:  Jianghong Huang; Yujie Liang; Meiquan Xu; Jianyi Xiong; Daping Wang; Qiang Ding
Journal:  Oncol Lett       Date:  2018-02-08       Impact factor: 2.967

Review 8.  The emerging role of miR-506 in cancer.

Authors:  Jian Li; Jingfang Ju; Bing Ni; Huaizhi Wang
Journal:  Oncotarget       Date:  2016-09-20

9.  MicroRNA-761 promotes the sensitivity of colorectal cancer cells to 5-Fluorouracil through targeting FOXM1.

Authors:  Shuguang Cao; Limiao Lin; Xuanping Xia; Hao Wu
Journal:  Oncotarget       Date:  2017-08-10

10.  MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression.

Authors:  Wang Jiashi; Qiu Chuang; Zhang Zhenjun; Wang Guangbin; Li Bin; He Ming
Journal:  Aging (Albany NY)       Date:  2018-06-10       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.